LATEST ALERTSUS company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
This interactive dashboard provides a detailed look at the current CBD market in Japan, including information about product formats, pricing and brands
This interactive dashboard provides a detailed look at the current CBD market in the Netherlands, including information about product formats, pricing and brands
This interactive dashboard provides a detailed look at the current CBD market in the United States, including information about product formats, pricing and brands
This interactive dashboard provides a detailed look at the current CBD market in France, including information about product formats, pricing and brands
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
This interactive dashboard provides a detailed look at the current CBD market in the UK, including information about product formats, pricing and brands
This report offers a comprehensive overview of the current regulatory framework in place in Denmark for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
The French Council of State has definitively ruled that a 2021 government decree banning hemp flowers is illegal and must be annulled. This major decision fully authorises French shops to sell CBD products, including flowers, without any fear of punishment for working outside the law
This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country
This interactive dashboard provides a detailed look at the current CBD market in Germany, including information about product formats, pricing and brands
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this time?
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
The United Nations may be growing more accepting of a global legal cannabinoid sector, but it does not believe many countries have the capacity to successfully regulate such markets
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
